Literature DB >> 18678623

The major limitation to exercise performance in COPD is lower limb muscle dysfunction.

Richard Debigaré1, François Maltais.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18678623     DOI: 10.1152/japplphysiol.90336.2008a

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


× No keyword cloud information.
  28 in total

1.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

2.  The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced emphysema.

Authors:  Yochai Adir; Jacob E Ollech; Baruch Vainshelboim; Yael Shostak; Arie Laor; Mordechai R Kramer
Journal:  Lung       Date:  2015-03-07       Impact factor: 2.584

3.  Evidence that a higher ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings.

Authors:  Gwenael Layec; Luke J Haseler; Jan Hoff; Russell S Richardson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-09       Impact factor: 3.619

4.  Effect of modified Total Body Recumbent Stepper training on exercise capacity and thioredoxin in COPD: a randomized clinical trial.

Authors:  Wentao Duan; Dan Zeng; Jin Huang; Jing Gu; San Li; Wei Zhou; Jinling Ma; Yan Jiang; Liming Zhu; Xudong Xiang; Aiguo Dai
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

5.  Comparison of Functional Capacity and Symptoms of COPD Patients with and without Pulmonary Hypertension.

Authors:  Fikriye Kalkan; Elif Yilmazel Ucar; Kamuran Kalkan; Omer Araz
Journal:  Eurasian J Med       Date:  2020-06-02

6.  Severe loss of mechanical efficiency in COVID-19 patients.

Authors:  Eulogio Pleguezuelos; Amin Del Carmen; Gemma Llorensi; Jessica Carcole; Paula Casarramona; Eva Moreno; Pilar Ortega; Mateo Serra-Prat; Elisabet Palomera; Marc M Miravitlles; Joan Carles Yebenes; Ramón Boixeda; Lluis Campins; Koldo Villelabeitia-Jaureguizar; Manuel Vicente Garnacho-Castaño
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-06-08       Impact factor: 12.063

7.  Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.

Authors:  Kai M Beeh; Dave Singh; Lilla Di Scala; Anton Drollmann
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-31

8.  Pulmonary rehabilitation: An overview.

Authors:  Bharat Bhushan Sharma; Virendra Singh
Journal:  Lung India       Date:  2011-10

9.  Satellite cells senescence in limb muscle of severe patients with COPD.

Authors:  Marie-Eve Thériault; Marie-Ève Paré; François Maltais; Richard Debigaré
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

10.  Gait mechanics in patients with chronic obstructive pulmonary disease.

Authors:  Jennifer M Yentes; Kendra K Schmid; Daniel Blanke; Debra J Romberger; Stephen I Rennard; Nicholas Stergiou
Journal:  Respir Res       Date:  2015-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.